首页> 外国专利> USE OF THERAPEUTIC CELLS TO OBTAIN CELLULAR RESPONSE TO INFECTION, TUMOURS OR AUTOIMMUNE-GENERATED CELLS, CELLS WITH CHIMAERIC RECEPTORS (WITH BINDING COMPONENT AND DESTRUCTION SIGNAL), DNA ENCODING THE RECEPTOR, VECTORS AND ANTIBODIES TO RECEPTOR

USE OF THERAPEUTIC CELLS TO OBTAIN CELLULAR RESPONSE TO INFECTION, TUMOURS OR AUTOIMMUNE-GENERATED CELLS, CELLS WITH CHIMAERIC RECEPTORS (WITH BINDING COMPONENT AND DESTRUCTION SIGNAL), DNA ENCODING THE RECEPTOR, VECTORS AND ANTIBODIES TO RECEPTOR

机译:使用治疗性细胞获得细胞对感染,肿瘤或自体产生的细胞的反应,带有化学受体的细胞(具有结合的成分和破坏信号),编码受体,载体和受体的DNA

摘要

Disclosed is a method of directing a cellular response in a mammal by expressing in a cell of the mammal a chimeric receptor which causes the cells to specifically recognize and destroy an infective agent, a cell infected with an infective agent, a tumor or cancerous cell, or an autoimmune-generated cell. Also disclosed are cells which express the chimeric receptors and DNA encoding the chimeric receptors.
机译:公开了一种通过在哺乳动物细胞中表达嵌合受体来指导哺乳动物细胞反应的方法,该嵌合受体可使细胞特异性识别并破坏感染因子,感染了感染因子的细胞,肿瘤或癌细胞,或自身免疫产生的细胞。还公开了表达嵌合受体的细胞和编码嵌合受体的DNA。

著录项

  • 公开/公告号NZ241855A

    专利类型

  • 公开/公告日1994-04-27

    原文格式PDF

  • 申请/专利权人 THE GENERAL HOSPITAL CORP;

    申请/专利号NZ19920241855

  • 发明设计人 SEED BRIAN;ROMEO CHARLES;

    申请日1992-03-05

  • 分类号A61K35/12;C12N5/06;C12N5/10;C12N15/12;C12N15/62;C12N15/63;C12N15/85;C07K15/28;C07K15/06;C12P21/08;

  • 国家 NZ

  • 入库时间 2022-08-22 04:44:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号